Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Decision-making in multiple sclerosis consultations in Italy: third observer and patient assessments.
Treatment of pediatric chronic inflammatory demyelinating polyneuropathy: Challenges, controversies and questions.
Adjusted Indirect Comparison of Oral Multiple Sclerosis Agents.
Targeting the 18-kDa translocator protein: recent perspectives for neuroprotection.
Urodynamics findings in transverse myelitis patients with lower urinary tract symptoms: Results from a tertiary referral urodynamic center.
Multiple sclerosis: Regenerative therapies for MS-hope on the horizon.
The B1-cell subpopulation is diminished in patients with relapsing-remitting multiple sclerosis.
Loss of astrocytic leptin signaling worsens experimental autoimmune encephalomyelitis.
SPatial REgression Analysis of Diffusion tensor imaging (SPREAD) for longitudinal progression of neurodegenerative disease in individual subjects.
Decoding movement intent of patient with multiple sclerosis for the powered lower extremity exoskeleton.
A randomized clinical trial of oral versus intravenous methylprednisolone for relapse of MS.
Adding to the burden: gastrointestinal symptoms and syndromes in multiple sclerosis.
Implanting glass spinal cord windows in adult mice with experimental autoimmune encephalomyelitis.
Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in relapsing-remitting multiple sclerosis patients on high-dose interferon β
Unethical for neurologists not to offer patients with multiple sclerosis chemotherapy with autologous stem cell support.
Serum 25(OH) Vitamin D levels is not associated with disability in multiple sclerosis patients: A case-control study.
[The specialised MS networks, at the heart of the organisation of patient paths].
Analysis of CH25H in multiple sclerosis and neuromyelitis optica.
High-Throughput Screening Platform for the Discovery of New Immunomodulator Molecules from Natural Product Extract Libraries.
Brain atrophy and lesion load predict long term disability in multiple sclerosis.
A Better Characterization of Spinal Cord Damage in Multiple Sclerosis: A Diffusional Kurtosis Imaging Study.
Tumefactive multiple sclerosis requiring emergency craniotomy: Case report and literature review.
Prognostic risk estimates of patients with multiple sclerosis and their physicians: comparison to an online analytical risk counseling tool.
Texture Analysis of T2-Weighted MR Images to Assess Acute Inflammation in Brain MS Lesions.
Cannabidiol limits Tcell-mediated chronic autoimmune myocarditis: implications to autoimmune disorders and organ transplantation.
Pages
« first
‹ previous
…
566
567
568
569
570
571
572
573
574
…
next ›
last »